Emerging Market ETF Guide: How to Invest in Developing Economies

• iShares Core MSCI EM IMI UCITS ETF (EIMI) — broadest coverage including small-caps, TER 0.18%, GBP/USD/EUR share classes available
• Vanguard FTSE Emerging Markets UCITS ETF (VFEM) — similar coverage, TER 0.22%
• iShares MSCI EM ex-China UCITS ETF — for investors wanting to reduce China concentration
• Mirae Asset NYSE FANG+ ETF (India-listed) — tech-focused EM exposure available in INR for Indian investors

EM investing carries risks that are materially different from developed market investing. Understanding them prevents unpleasant surprises:

• Currency risk: EM currencies are more volatile than USD/EUR/GBP. A Brazilian real devaluation, Turkish lira crisis, or Indian rupee depreciation directly affects the USD value of your ETF.
• Political risk: government interference, nationalisation, regulatory changes are more common in EM. China's 2021 crackdown on tech and education sectors erased 50–80% of value from affected stocks within weeks.
• Liquidity risk: in a market downturn, EM ETFs can experience wider bid-ask spreads and difficulty executing at the expected price.
• Index inclusion changes: MSCI and FTSE periodically reclassify countries. Pakistan was demoted from EM to Frontier Markets (2017). If MSCI reclassifies China, EM ETFs will sell massive amounts of Chinese stocks, potentially affecting prices.
• Governance: corporate governance standards in EM are generally weaker. Related-party transactions, minority shareholder abuse, and accounting fraud are more common.

A global market-cap weighted index (like VWRA) already includes 10–15% in emerging markets. Should you overweight EM above this baseline? The considerations:

• The case for market-cap weight (10–15% EM): you accept that markets efficiently price risk and return. No need to second-guess global capital allocation.
• The case for overweighting EM (20–30%): EM countries represent ~40% of global GDP but only 10–15% of stock market value. The GDP-to-market-cap gap could narrow as EM financial markets develop. Some investors call this a long-term convergence trade.
• The case for underweighting EM (5% or less): EM has historically delivered only marginally better returns than developed markets with significantly higher volatility. The risk-adjusted case for EM overweighting is weak.
• Practical recommendation: hold EM at market-cap weight (through VWRA) unless you have a strong conviction thesis. Overweighting requires accepting higher volatility and a longer patience horizon.

China represents 27% of the MSCI EM index. For investors who want EM exposure but are concerned about China regulatory, geopolitical, or governance risk, there are options:

• iShares MSCI EM ex-China UCITS ETF: excludes Chinese stocks entirely. The remaining EM portfolio is weighted more towards India, Taiwan, South Korea, Brazil, and others. TER: 0.18%.
• Combined approach: hold EIMI (standard EM) plus a small position in India-specific ETF (e.g., iShares MSCI India ETF, NDIA) to increase India weight specifically.
• India-only ETFs for Indian investors: if you're an Indian investor wanting EM without China, simply buy Indian equity (Nifty 50) for domestic exposure and developed-market UCITS ETFs (CSPX, IWDA) for international. This entirely avoids the China question.

Non-US investors should prioritize UCITS-domiciled ETFs (Ireland or Luxembourg) over US-domiciled funds to avoid US estate tax exposure and optimize withholding tax treatment. The UCITS EM ETF universe has grown substantially, and tracking differences between the top funds are now under 0.3% per year.

• iShares Core MSCI EM IMI UCITS ETF (EIMI): 0.18% TER, covers 3,000+ stocks including small-caps. Accumulating version: SAEM. Domiciled in Ireland. Tracks MSCI Emerging Markets Investable Market Index.
• Vanguard FTSE Emerging Markets UCITS ETF (VFEM): 0.22% TER. Tracks FTSE Emerging Markets index — note this excludes South Korea (classified as developed) unlike MSCI.
• Xtrackers MSCI EM UCITS ETF (XMME): 0.18% TER. Slightly different sampling methodology. Available in distributing and accumulating share classes.
• iShares MSCI EM ex-China UCITS ETF: newer option for investors wanting EM exposure while underweighting China's ~30% index weighting. 0.18% TER.
• For US-resident investors: VWO (Vanguard, 0.08% TER) and IEMG (iShares, 0.09%) offer lower costs but come with US estate tax risk for non-US persons.

The MSCI Emerging Markets Index is heavily concentrated in a small number of countries. As of early 2026, the top 5 countries account for approximately 75% of the index: China (~30%), India (~19%), Taiwan (~18%), South Korea (~12%), and Brazil (~5%). This concentration has significant implications for investors.

• China concentration: political and regulatory risk is substantial. The 2021 tech crackdown erased 60–80% of value from Chinese tech stocks in months. The index has since reduced China's weight but remains concentrated.
• India premium: India's weight has grown from ~8% to ~19% in five years, driven by strong growth and foreign inflows. Indian investors buying an EM ETF are buying significant India exposure on top of their existing domestic holdings.
• Taiwan semiconductor exposure: TSMC alone represents ~9% of the MSCI EM index. Geopolitical risk around Taiwan Strait tensions is a real factor.
• FTSE vs MSCI: the FTSE EM index classifies South Korea as developed (excluded) while MSCI still classifies it as emerging (included). This creates a 12% weight difference — check which index your ETF tracks.

The case for emerging markets rests on three pillars: higher long-run GDP growth, lower valuations, and diversification benefits. The counter-case is that EM equities have dramatically underperformed developed markets over the past 15 years (2010–2025), with MSCI EM returning approximately 5% annualized vs 12% for MSCI World over this period.

• Valuation: MSCI EM trades at roughly 12–14× forward earnings vs 18–20× for MSCI World. Cheaper valuations theoretically imply higher future returns.
• Currency drag: EM currencies tend to depreciate against USD over time, reducing returns for dollar-based investors. EIMI hedges this partially via fund-level FX management.
• Governance risk: shareholder rights and corporate governance in many EM countries are weaker than in developed markets. State-owned enterprises dominate Chinese and Brazilian indices.
• Recommended allocation: many financial planners suggest 10–20% EM within a global equity allocation — enough to benefit from diversification without overweighting the risks.

• Q: Which EM ETF has the lowest cost for UK investors? A: EIMI (iShares MSCI EM IMI, 0.18% TER) is the cheapest broad EM ETF for UK UCITS investors. It covers large, mid, and small-cap EM stocks (~3,000 companies). VFEM (Vanguard FTSE EM, 0.22%) and XMME (Xtrackers MSCI EM, 0.18%) are comparable.
• Q: Should I buy an EM ETF separately or is it included in VWRA? A: VWRA includes approximately 11–12% EM allocation at current FTSE All-World weights. If you want more EM tilt, add EIMI separately. If you're happy with market-cap EM weight, VWRA alone is sufficient.
• Q: How much of EIMI is China? A: Approximately 25–30% of MSCI EM is China (varies with market movements). If you want EM exposure while reducing China weight, consider EMXC (iShares MSCI EM ex-China) which explicitly excludes Chinese stocks.
• Q: Is India in EM ETFs? A: Yes. India represents approximately 18–20% of MSCI EM as of 2025–26. NRI investors buying EM ETFs through IBKR are thus adding to their India exposure — factor this into your India allocation decision.
• Q: Why have EM stocks underperformed developed markets over 15 years? A: Multiple factors: China regulatory crackdowns erased 60–80% of Chinese tech value in 2021, EM currencies depreciated against USD, and US tech companies (not in EM) massively outperformed. Valuation gap (EM at 12× vs DM at 18–20×) argues for better future EM returns, but the timing is uncertain.